
Phase 2 data show RAP-219 eases acute bipolar mania with significant YMRS gains and encouraging tolerability, setting the stage for FDA talks and phase 3 plans.
Why does prazosin appear to be the safest and most effective medication for select patients with comorbid PTSD?
